Albemarle Corporation’s Stock Price Soars to $104.96, Marking a Robust 3.82% Uptick in Market Performance

Albemarle Corporation (ALB)

104.96 USD +3.86 (+3.82%) Volume: 1.53M

Albemarle Corporation’s stock price stands at 104.96 USD, marking a positive trading session with a percentage change of +3.82% and a robust trading volume of 1.53M, despite a Year-to-Date (YTD) decline of -27.35%, indicating potential growth opportunities for investors in the chemical industry.

Latest developments on Albemarle Corporation

Albemarle Corp has been making headlines recently with key events affecting its stock price movements. Capital World Investors have increased their stake in the company, while Rockefeller Capital Management L.P. purchased over 10,000 shares of Albemarle Co. This comes after the company’s stock price experienced a 3.73% decrease on December 4th. Edgestream Partners L.P. also acquired new holdings in Albemarle Co., further impacting its market performance. With all these developments, investors are closely watching Albemarle Corp as its stock price continues to fluctuate.

Albemarle Corporation on Smartkarma

Analysts at Baptista Research on Smartkarma have published two research reports on Albemarle Corporation. In one report titled “Albemarle Corporation: Will Its Volume Growth & Asset Utilization Help Bring A Shift In The Competitive Dynamics? – Major Drivers,” the analysts highlight the company’s strong Q3 2024 earnings, with volumetric growth in its Energy Storage division and year-over-year EBITDA growth in its Specialties and Ketjen segments. The report also mentions Albemarle’s solid liquidity and leverage metrics, with leverage well below covenant limits and operating cash conversion of over 100%. Baptista Research aims to evaluate various factors that could impact the company’s stock price in the near future and conducts an independent valuation using a Discounted Cash Flow (DCF) methodology.

Another report by Baptista Research, titled “Albemarle Corporation: These Are The 7 Factors Driving Our ‘Buy’ Rating! – Financial Forecasts,” discusses Albemarle’s Q2 2024 earnings, which showed a mix of operational successes and challenges in line with the industry landscape. The company reported a significant decrease in net sales to $1.4 billion from $2.4 billion the previous year, primarily due to decreased pricing. Albemarle recorded a loss of $188 million, marking a substantial downturn from profitability, with a diluted loss per share of $1.96. Despite these challenges, Baptista Research identifies seven factors driving their ‘Buy’ rating on Albemarle Corporation, indicating confidence in the company’s future performance.

A look at Albemarle Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Albemarle Corp, a company that produces specialty and fine chemicals, has received high scores on several factors according to Smartkarma Smart Scores. With a strong Value score of 4, Albemarle is considered to be a valuable investment option. Additionally, the company has shown resilience with a score of 4, indicating its ability to withstand market fluctuations and challenges. This suggests a positive long-term outlook for Albemarle Corp.

Although Albemarle Corp has received lower scores in Growth and Dividend factors, with scores of 2 and 3 respectively, its Momentum score of 5 highlights the company’s strong performance and potential for future growth. Overall, Albemarle Corp‘s high scores in Value, Resilience, and Momentum indicate a promising outlook for the company in the long term, making it a potentially attractive option for investors.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma